4 Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) is the most widely used formula for eGFR in the UK. This formula considers multiple factors that can influence creatinine production ...

Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...

Improving Global Outcomes organization's updates to its 2024 guidelines expand SGLT2 inhibitor use and refine chronic kidney ...

Research shows multiple factors drive CKD risk in lupus nephritis, including nephritic flares, baseline hypertension, renal ...

In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.

Use of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization ...

Chronic Kidney Disease (CKD) indicates prolonged kidney damage over three months, often undetectable until significant harm ...

Objective Many societies recommend using estimated glomerular filtration rate (eGFR) rather than serum creatinine (sCr) to determine metformin eligibility. We examined the potential impact of ...

The following is a summary of “Effects of SGLT2 inhibition on insulin use in CKD and type 2 diabetes: Insights from the CREDENCE trial,” published in the February 2025 issue of Nephrology Dialysis ...

Alarmingly, data indicates that in the United States, fewer than 50% of adults have normal kidney function, and over 50% are likely to develop CKD in their ... Stage 4: GFR 15-29% (severe ...

Syndromic surveillance is the collection of health data based on syndromes. A syndrome is a pattern or collection of symptoms related to an illness. Maine CDC collects this information from medical ...